GSK, Endometrial Cancer and European Commission

GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer
GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary, advanced or recurrent endometrial cancer.
EU approves endometrial, lung cancer drugs from GSK and J&J
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third-generation EGFR tyrosine kinase inhibitor Lazcluze (lazertinib) as a first-line treatment for locally advanced and metastatic NSCLC with exon 19 deletions or exon 21 L858R substitutions.
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant trial results.
GSK announces expanded EU approval in endometrial cancer for Jemperli combo
GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use
GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU to treat certain adults with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) endometrial cancer.
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer
London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult
Hosted on MSN4h
Endometrial cancer rising among Malaysian women under 35
This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...
Medscape3d
Does Chemoradiotherapy Boost Survival in Endometrial Cancer?
The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...
Cancer Rates Are Rising in Young Women. Here’s How to Lower Your Risk
Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...
EurekAlert!1d
Improving uterine manipulation techniques in laparoscopic hysterectomy
Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...
Cancer Therapy Advisor3d
Long-Acting, Reversible Contraceptives Linked to Increased Risk of Cancer
Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.